Home » Topics » Conferences

Conferences
RSS

Another series of mGluR antagonists from Lilly

Sep. 20, 1996

Metabotropic glutamate receptor antagonists from Lilly

Sep. 20, 1996

New dopamine D4 receptor antagonists from Taisho and Nihon Nohyaku

Sep. 20, 1996

Mitochondrial benzodiazepine receptor (MBR) ligands as potential anxiolytics

Sep. 20, 1996

Glaxo Wellcome identifies potential anxiolytic agents

Sep. 20, 1996

New topical triazole antifungal agent from Kaken

Sep. 20, 1996

Optically active triazole antifungal agent from Takeda

Sep. 20, 1996

Safe, broad-spectrum quinolones from Wakunaga

Sep. 20, 1996

New quinolone from Bayer undergoing extensive evaluation

Sep. 20, 1996

Potential new analgesic agent from SmithKline Beecham

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...